Home/Filings/4/0001654954-21-011339
4//SEC Filing

DAHL ANDREW A 4

Accession 0001654954-21-011339

CIK 0001101026other

Filed

Oct 24, 8:00 PM ET

Accepted

Oct 25, 7:07 PM ET

Size

5.3 KB

Accession

0001654954-21-011339

Insider Transaction Report

Form 4
Period: 2021-10-21
DAHL ANDREW A
President, CEO
Transactions
  • Award

    Nonstatutory Stock Option to Purchase Common Stock

    2021-10-21+376,000376,000 total
    Exercise: $5.50Exp: 2031-10-20Common Stock (376,000 underlying)
Footnotes (1)
  • [F1]The option was issued pursuant to the 2021 Equity Incentive Plan and vests as follows: 25% upon acceptance of the grant, and 25% on each of the next three calendar anniversaries of the grant.

Issuer

Zivo Bioscience, Inc.

CIK 0001101026

Entity typeother

Related Parties

1
  • filerCIK 0001537603

Filing Metadata

Form type
4
Filed
Oct 24, 8:00 PM ET
Accepted
Oct 25, 7:07 PM ET
Size
5.3 KB